Article Information
PubMed
Published By
Online ISSN
History
- Received July 30, 2021
- Revision received November 12, 2021
- Accepted November 12, 2021
- Published online November 24, 2021.
Copyright & Usage
© 2021 Miyashita et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Author Information
- Yusuke Miyashita, Data curation, Formal analysis, Validation, Investigation, Writing—original draft, review, and editing1,2,
- Takahisa Kouwaki, Data curation, Investigation1,
- Hirotake Tsukamoto, Data curation, Supervision, Investigation, Writing—original draft, review, and editing1,3⇑,
- Masaaki Okamoto, Data curation, Investigation1,
- Kimitoshi Nakamura, Conceptualization, Supervision, Project administration2 and
- Hiroyuki Oshiumi, Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing—original draft, review, and editing1⇑
- 1Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
- 2Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
- 3Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
- Correspondence: oshiumi{at}kumamoto-u.ac.jp
- tsukamoto.hirotake.4j{at}kyoto-u.ac.jp
Funding
Japan Society for the Promotion of Science (JSPS) KAKENHI
JPH03480 and 19H03480Japan Agency for Medical Research and Development
TICAM-1 is a negative regulator of IL-17RA signaling
In this Issue
Advertisement